{"title":"Application of DOE to ELISA Robustness and Ruggedness Assessment.","authors":"Thy Follmer, Seth Clark, Thorsten Verch","doi":"10.1208/s12248-025-01048-3","DOIUrl":null,"url":null,"abstract":"<p><p>Complex assays such as immunoassays can be affected by robustness and ruggedness factors. Associated risks can be reduced by a systematic performance assessment across key factors followed by control strategies. However, the large number of factors and their interactions can represent an experimental challenge. Statistical Design of Experiments (DOE) allows efficient evaluation of more factors with fewer total assay runs in addition to assessing potential factor interactions. We applied DOEs to the robustness evaluation of a vaccine potency ELISA. Test factors were selected based on a review and ranking of development data, scientific experience, and commonly expected sources of variability. Comparing different design options with 16-20 runs which was a laboratory limit, a 16-run Resolution III design was selected based on the total number of runs, the degree of factor confounding, and the potential projection properties. DOE data were first visually analyzed by plotting the concentration-responses of reference curves against DOE Runs followed by detailed statistical models of the maximum fluorescent curve signal and the WRMSE fit values. Initial confounding between factors and their interactions was reduced by eliminating factors with no impact from the models and by removing factors or interactions based on their likelihood of an impact after applying statistical and scientific expertise. Despite initial confounding, the designs allowed discerning an impact of plate manufacturer with interaction of coating concentration and time out of 15 factors with only 16 runs.</p>","PeriodicalId":50934,"journal":{"name":"AAPS Journal","volume":"27 3","pages":"74"},"PeriodicalIF":5.0000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AAPS Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1208/s12248-025-01048-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Complex assays such as immunoassays can be affected by robustness and ruggedness factors. Associated risks can be reduced by a systematic performance assessment across key factors followed by control strategies. However, the large number of factors and their interactions can represent an experimental challenge. Statistical Design of Experiments (DOE) allows efficient evaluation of more factors with fewer total assay runs in addition to assessing potential factor interactions. We applied DOEs to the robustness evaluation of a vaccine potency ELISA. Test factors were selected based on a review and ranking of development data, scientific experience, and commonly expected sources of variability. Comparing different design options with 16-20 runs which was a laboratory limit, a 16-run Resolution III design was selected based on the total number of runs, the degree of factor confounding, and the potential projection properties. DOE data were first visually analyzed by plotting the concentration-responses of reference curves against DOE Runs followed by detailed statistical models of the maximum fluorescent curve signal and the WRMSE fit values. Initial confounding between factors and their interactions was reduced by eliminating factors with no impact from the models and by removing factors or interactions based on their likelihood of an impact after applying statistical and scientific expertise. Despite initial confounding, the designs allowed discerning an impact of plate manufacturer with interaction of coating concentration and time out of 15 factors with only 16 runs.
期刊介绍:
The AAPS Journal, an official journal of the American Association of Pharmaceutical Scientists (AAPS), publishes novel and significant findings in the various areas of pharmaceutical sciences impacting human and veterinary therapeutics, including:
· Drug Design and Discovery
· Pharmaceutical Biotechnology
· Biopharmaceutics, Formulation, and Drug Delivery
· Metabolism and Transport
· Pharmacokinetics, Pharmacodynamics, and Pharmacometrics
· Translational Research
· Clinical Evaluations and Therapeutic Outcomes
· Regulatory Science
We invite submissions under the following article types:
· Original Research Articles
· Reviews and Mini-reviews
· White Papers, Commentaries, and Editorials
· Meeting Reports
· Brief/Technical Reports and Rapid Communications
· Regulatory Notes
· Tutorials
· Protocols in the Pharmaceutical Sciences
In addition, The AAPS Journal publishes themes, organized by guest editors, which are focused on particular areas of current interest to our field.